Anonymous ID: a5869c Dec. 12, 2022, 9:42 a.m. No.17929301   🗄️.is 🔗kun   >>9363 >>9369 >>9436 >>9539 >>9672 >>9772 >>9837

https://www.msn.com/en-us/health/medical/opinion-thought-mrna-vaccines-would-end-with-the-pandemic-think-again/ar-AA15aYd7?ocid

 

CNN

 

Opinion: Thought mRNA vaccines would end with the pandemic? Think again

Opinion by Kirsi Goldynia • 5h ago

 

Many think the now-famous mRNA vaccines came into existence in the blink of an eye, at warp speed, in the throes of a deadly pandemic. But for Drew Weissman, who, along with his research partner Katalin Karikó, is credited with developing the platform that made the life-saving mRNA vaccines possible, RNA technology was a long time coming.

 

Weissman, 63, grew up in Lexington, Massachusetts, before attending Brandeis University, and then receiving both a doctorate and a medical degree from Boston University. He eventually landed a fellowship in Dr. Anthony Fauci’s lab at the National Institute of Allergy and Infectious Disease, where he spent the better part of the ’90s researching dendritic cells, a key biological player in starting the body’s immune response. So, when he found himself at the University of Pennsylvania in 1997, the question of how to bolster the human immune system was already burning in his mind.

 

Then, serendipity stepped in. Weissman bumped into Karikó, a biochemist at the university, while waiting at the Xerox machine for articles to be photocopied. They began talking about their shared research interest. Karikó, a native of Hungary, had spent decades researching messenger RNA – the biological instruction manual for the production of proteins in human cells – and was convinced of the potential it held for human therapeutics.

 

Just like that, a scientific dream team was formed.

 

Drew Weissman and Katalin Karikó are credited with developing the platform that made mRNA vaccines possible. - Courtesy Penn Medicine

Their research, however, was an uphill battle. For years, Weissman and Karikó’s experiments with RNA ended in failure. The key problem: The RNA was provoking an immune response that made their lab mice sick. But in 2005, with little support left from the scientific community, the pair had a breakthrough. They realized that by modifying the RNA, it would subvert detection by immune cells, and the proteins that the body synthesized from the RNA would train the immune system to recognize a specific foreign invader. With this modified RNA, the mice no longer got sick and showed the immunity Weissman and Karikó had hoped for.

 

So, when the Covid-19 pandemic hit, it didn’t take long – just the amount of time to sequence the genome of the SARS-CoV-2 virus, create the mRNA based on that sequence and send the final product through the regulatory process – for a safe and effective Covid-19 mRNA vaccine to be approved for use.

 

Since then, millions of lives have been saved by the vaccines. Covid-19 is still a threat, but vaccinated and boosted Americans have largely been able to return to a normal cadence of life.

Anonymous ID: a5869c Dec. 12, 2022, 9:51 a.m. No.17929359   🗄️.is 🔗kun   >>9367 >>9399 >>9436 >>9443 >>9539 >>9672 >>9772 >>9837

https://www.msn.com/en-us/health/health-news/judge-rejects-vaccine-choice-law-in-health-care-settings/ar-AA15bvxq?ocid

 

The Associated Press

 

Judge rejects vaccine choice law in health care settings

Story by By AMY BETH HANSON, Associated Press • 1h ago

 

HELENA, Mont. (AP) — A person's choice to decline vaccinations does not outweigh public health and safety requirements in medical settings, a federal judge ruled in a Montana case.

 

of course a bill clinton judge

Anonymous ID: a5869c Dec. 12, 2022, 11:10 a.m. No.17929778   🗄️.is 🔗kun

https://www.msn.com/en-us/news/politics/biden-official-hid-info-about-meetings-with-george-soros-hillary-clinton-nancy-pelosi-from-public/ar-AA15bPw7?ocid

 

 

FOX News

Biden official hid info about meetings with George Soros, Hillary Clinton, Nancy Pelosi from public

Story by Thomas Catenacci • 2h ago

 

Meanwhile — on Sept. 6, 2021, about two weeks after the meeting between Gensler and Soros — the Wall Street Journal published an op-ed written by Soros. Gensler's private calendar, but not his public calendar, states the purpose of the Aug. 20 meeting was "re: WSJ op-ed."

 

In the article, Soros blasted major asset manager BlackRock for launching investment products for Chinese customers while applauding the company's environmental policies. Soros eventually argued that Congress should pass legislation giving the already-powerful SEC more regulatory authority.